Pharmacological treatment with fasudil in bleomycin-induced pulmonary fibrosis reduced the production of TGF-β1, α-SMA, CTGF, and plasminogen activator inhibitor-1 (PAI-1) [182]. This evidence concerns the gene TGFB1 and pulmonary fibrosis.